Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Bavarian Nordic
Company

Bavarian Nordic

Tracked across 2 events · 15 articles · First seen Feb 02, 2026 · Last active Mar 16, 2026

Sentiment
40
Attention
4
Events
2
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 70
Business
Bavarian Nordic, Serum Institute Expand Chikungunya Vaccine Partnership
Bavarian Nordic has expanded its strategic partnership with Serum Institute of India, transferring the manufacturing process for its chikungunya vaccine. This move is expected to scale global supply and improve access to the vaccine, positively impacting Bavarian Nordic's market position and revenue.
Mar 11, 2026 · 7 articles
2 10
Business
Bavarian Nordic Share Buy-Back Update
Bavarian Nordic A/S is executing a share buy-back program to repurchase shares for up to DKK 200 million, which can positively impact its stock price and shareholder value by reducing the number of outstanding shares.
Feb 02, 2026 · 8 articles
Key Actions (2)
100 Bavarian Nordic launched share buy-back programBavarian Nordic Share...
90 Bavarian Nordic repurchased sharesBavarian Nordic Share...
Relationships (1)
Paul Chaplin President & CEO ↔ Bavarian Nordic Paul Chaplin is the President & CEO of Bavarian Nordic.
NEWSDESK
Track Bavarian Nordic live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.